New Hope for People Battling With Depression | Bloomberg Businessweek
Автор: Bloomberg Podcasts
Загружено: 2025-12-08
Просмотров: 415
Описание:
Compass Pathways is a mental health care company developing new treatments for people who haven’t responded to existing medications and continue to struggle with their mental health. The company was the first to report successful Phase 3 clinical trial results for a psychedelic treatment, known as COMP360 psilocybin, for treatment-resistant depression (TRD) and is positioned to potentially be the first to receive regulatory approval and bring a psychedelic-based medicine to market.
Kabir Nath, the CEO of Compass Pathways, details his company's path building a scalable, safe, and accessible psychedelic care system and model. Kabir speaks with Carol Massar and Alexis Christoforous on Bloomberg Businessweek Daily.
See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.
Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.
Subscribe to Bloomberg Podcasts: https://bit.ly/BloombergPodcasts
Listen to more of Bloomberg Businessweek: • Bloomberg Businessweek
#Bloomberg #Podcast #News #Businessweek
Visit us: https://www.bloomberg.com/podcasts
Follow Bloomberg Podcasts on Twitter: / podcasts
Visit our other YouTube channels:
Bloomberg Television: / @markets
Bloomberg Originals: / bloomberg
Quicktake: / @bloombergquicktake
For coverage on news, markets and more: http://www.bloomberg.com/video
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: